SCLX Q3 2021 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$72M

Q3 2021 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$8M+41.3% YoY

Gross Profit

$7M85.9% margin

Operating Income

-$7M-88.5% margin

Net Income

-$12M-144.4% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

-9.7%

Cash Flow

Operating Cash Flow

-$134,785

Free Cash Flow

-$134,790

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$140M

Total Liabilities

$10M

Stockholders' Equity

$130M

Cash & Equivalents

$115,642

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+41.3%
Gross Profit	$7M	$5M	+33.6%
Operating Income	-$7M	-$9M	+16.5%
Net Income	-$12M	-$12M	-1.2%